Seeking Alpha

Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety...

Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety violations, including "failure to develop adequate written procedures for the surveillance, receipt, evaluation, and reporting of postmarketing adverse drug experiences to FDA."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs